SYNOPSIS Carcinoembryonic antigen (CEA) has been measured in parallel with seven serum proteins and seromucoids in the sera of patients with malignant neoplasia and non-neoplastic disease. In the total group significant correlations were found between CEA and seromucoids and between CEA and several serum proteins. However, with two exceptions, when the individual disease groups were examined no correlation was seen. It is concluded that abnormal concentrations of the specific proteins measured do not consistently interfere in the CEA radioimmunoassay and do not explain the high CEA levels in patients with non-neoplastic diseases.
A major defect in the application of carcinoembryonic antigen (CEA) assay to diagnostic clinical practice lies in the lack of specificity for cancer as against inflammatory disease. This finding has been widely confirmed (Moore, Kupchik, Marcon, and Zamcheck, 1971; Laurence, Stevens, Bettleheim, Darcy, Leese, Turberville, Alexander, Johns, and Neville, 1972; Booth, King, Leonard, and Dykes, 1973) , and although marginal differences exist between laboratories, elevated levels have been consistently found in a considerable proportion of patients with inflammatory disease of the bowel, cirrhosis, and chronic lung disease.
In neoplastic and inflammatory processes marked elevation of serum glycoproteins may occur (Macbeth and Bekesi, 1962; Bacchus, Kennedy, and Blackwell, 1967; Snyder and Ashwell, 1971) , and the possibility exists that such elevation, of one or more of these proteins, might in some way be responsible for false positive CEA results. It may be difficult using radioimmunoassay as the method of measurement to distinguish between a highly active antigen such as CEA, itself a glycoprotein present in nanogram amounts, and other weakly cross-reacting proteins present in concentrations a thousand times greater. Interference with radioimmunoassay might also be due to entirely non-specific effects associated Received for publication 8 November 1973. 130 with marked changes in the concentration of certain serum proteins. Possible mechanisms include the masking of antibody binding sites for CEA and the effect on the coprecipitation of labelled antigen. An example of non-specific effects in radioimmunoassay has been reported by Girard and Greenwood (1969) who showed that salt and urea in urine simulated the presence of growth hormone. In a study comparing methods for the radioimmunoassay of plasma insulin (Cotes, Mussett, Berryman, Ekins, Glover, Hales, Hunter, Lowy, Neville, Samols, and Woodward, 1969 ) there was evidence that methods which used albumin solution instead of treated plasma to dilute insulin standards could not distinguish some non-insulin components of plasma from insulin.
Elevations of CEA concentration have been found in patients with ulcerative colitis and Crohn's disease (Lo Gerfo, Krupey, and Hansen, 1971; Booth et al, 1973) . In these conditions there is marked elevation of the seromucoid fraction (Cooke, Fowler, Cox, Gaddie, and Meynell, 1958) . This fraction is a heterogeneous mixture of glycoproteins characterized by their solubility in perchloric acid and is composed mainly of alpha1 acid glycoprotein together with some alpha1 antitrypsin, haptoglobin, and traces of many other serum proteins (Schultze and Heremans, 1966) . It may be significant that the original method of CEA radioimmunoassay (Thom-son, Krupey, Freedman, and Gold, 1969) (Thomson, personal communication, 1971 ) that simply doubling the quantity of serum extracted for the assay leads to a marked increase in the number of positive results, and halving the quantity of serum reduces the number of positive results after making allowance for the volume extracted. Such findings, therefore, raise doubts about the specificity of CEA radioimmunoassay.
In more recent methods whole serum or plasma is used instead of perchloric acid extracts, and it is possible that serum proteins, other than glycoproteins, might interfere when present in abnormal concentrations.
The (Booth et al, 1973) . Carcinoembryonic antigen was measured by radioimmunoassay using the double antibody technique (Egan, Lautenschleger, Coligan, and Todd, 1972) as modified by Laurence et al (1972) .
Seromucoids were measured by a semi-automated modification of the method of Mandel, Gorsuch, and Cooper (1955) .
The specific proteins were measured by quantitative immunoelectrophoresis using the method of Laurell (1966 CEA on the one hand and seromucoids, ceruloplasmin, and haptoglobin on the other. A significant negative correlation (p < 0-05) was found for CEA and transferrin but there was no significant correlation with either of the immunoglobulins measured. 
Discussion
The double antibody radioimmunoassay estimates the CEA concentration of whole serum. It has been shown to give results comparable with those obtained using other radioimmunoassay techniques where CEA concentration is measured on perchloric acid extracts of serum (Laurence et al, 1972) . Thus if non-specific protein interference accounts for some falsely high CEA levels, it is likely that the interfering protein is extracted by perchloric acid.
Correlation between CEA and other serum protein concentrations appears poor, and, although levels of significance are reached in a number of instances, 
